Georgetown Lombardi, Washington's only National Cancer Institute-designated Comprehensive Cancer Center, serves as the research engine for MedStar Health, Georgetown University’s clinical partner. Georgetown Lombardi is also an NCI-recognized research consortium with John Theurer Cancer Center/Hackensack Meridian Health in Bergen County, New Jersey.
Georgetown Lombardi Comprehensive Cancer Center, part of Georgetown University Medical Center, seeks to prevent, treat and cure cancers by linking scientific discovery, expert and compassionate patient care, quality education and partnership with the community — guided by the principle of cura personalis, “care for the whole person.” Georgetown Lombardi is the research engine driving clinical cancer research at MedStar Health in the D.C. Metro area and northern New Jersey.
Georgetown University President John J. DeGioia discusses the significance of Georgetown Lombardi’s research:
Established in 1970, the Georgetown Lombardi Comprehensive Cancer Center is named for legendary football coach Vince Lombardi, who was treated for cancer at Georgetown University Hospital. What began as a small clinic treating cancer patients has grown into a state-of-the-art cancer center housing more than 240,000 square feet of clinic and research space. The director of the Cancer Center is Louis M. Weiner, MD.
In 1974, Georgetown Lombardi became the 16th National Cancer Institute (NCI)-designated Comprehensive Cancer Center in the country. Today, we remain the only center with this designation in the Washington, D.C., area.